Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Harvard Scientific (HVSF)Hot$$- male impotency medicine -- Ignore unavailable to you. Want to Upgrade?

To: Michael Brey who wrote (3451)	4/29/1998 9:17:00 PM
From: Dan Dieffenwierth	Read Replies (1) \| Respond to of 3906

Viagra has been dispensed to the patient for only a couple of weeks. I don't understand how they can say they have 32 times as many customers as Vivus has already. There is script data that is kept on companies. I'd sure like to see what they are as of now. I know they will do extremely well to begin with but I didn't know they would be that far along so soon. Yes, if it were a perfect world we would all be sitting pretty good about now. But there's that "if" word. I believe HVSF was hoping for the okay to start phase II in April, but with one more day to go, I don't think it will happen. Hopefully it will be soon though. I would also like to know something about the Springrange suit. Looked to me like they sold their shares before they filed suit knowing it would cause the price to drop. I wonder if they bought back in when it hit the low? Hmmm.... I hope they get their butt kicked. Sure could use some good news about now. Dan